Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SODIV ALSACE

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 3
Lead investments 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
Summary

The fund was located in Europe if to be more exact in France. The main office of represented Corporate Investor is situated in the Mulhouse.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the SODIV ALSACE, startups are often financed by Sofinnova Partners, Idinvest Partners, Groupe Siparex. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Auriga Partners, Alsace Business Angels. In the next rounds fund is usually obtained by Seventure Partners, Michael J. Fox Foundation, Financiere De l'Echiquier.

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2012. The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations.

We can highlight the next thriving fund investment areas, such as Commercial, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Domain Therapeutics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - France.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of SODIV ALSACE:
Typical Co-investors
SODIV ALSACE is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after SODIV ALSACE:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Avista Development Spokane, United States, Washington
car2go Israel, Tel Aviv, Tel Aviv District
Fuqua Investments -
GLS Ventures Sugar Land, Texas, United States
Guillemot Corporation Bretagne, Chantepie, France
Huaxin Ziyuan China, Guangdong, Shenzhen
iTo -
Jaguar Land Rover Tech Incubator Oregon, Portland, United States
Liga Ventures Brazil, São Paulo, Sao Paulo
NICE Group Seoul, Seoul-t'ukpyolsi, South Korea

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Rhenovia Pharma

Biotechnology
Health Diagnostics
Therapeutics
$637K12 Feb 2014 Grand Est

Firalis

Biotechnology
Commercial
Health Care
Industrial
$531K30 Jun 2010 Grand Est

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SODIV ALSACE?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 1M
Peak activity year 2012
Lead investments 1
Group Appearance index 0.67

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Rhenovia Pharma

Biotechnology
Health Diagnostics
Therapeutics
$637K12 Feb 2014 Grand Est

Firalis

Biotechnology
Commercial
Health Care
Industrial
$531K30 Jun 2010 Grand Est
Crunchbase icon

Content report

The following text will be sent to our editors: